Vitkauskiene Astra, Dudzevicius Vytis, Ryskus Liutauras, Adukauskiene Dalia, Sakalauskas Raimundas
Laboratory of Microbiology, Kaunas University of Medicine Hospital, Kaunas, Lithuania.
Medicina (Kaunas). 2006;42(4):288-93.
To determine the relationship between the production of extended-spectrum beta-lactamases (ESBLs) in Klebsiella pneumoniae (K. pneumoniae) strains resistant to third-generation cephalosporins and resistance of these strains to antibiotics used.
A total of 157 cultures of K. pneumoniae resistant to third-generation cephalosporins were obtained from bronchial secretions of patients treated in intensive care units (ICUs) at Kaunas University of Medicine Hospital (KUMH). The secretions were cultured, and antibacterial susceptibility was tested in the Laboratory of Microbiology at KUMH according to the recommendations of the National Committee for Clinical Laboratory Standards (NCCLS). Using a method of double-disc synergy test, K. pneumoniae strains possibly producing ESBL were considered for further testing by means of E-tests. The resistance to carbapenems, piperacillin, gentamycin, amikacin, and ciprofloxacin was compared between ESBL-producing and non-ESBL-producing K. pneumoniae strains resistant to third-generation antibiotics.
Almost one-third of K. pneumoniae strains (n=28, 32.8%) were resistant to third-generation cephalosporins in 2001 and 50.0% (n=36)--in 2004 (p<0.05). Half of the strains (n=7, 50%) were producing ESBLs in 2001 and 50% (n=12)--in 2004. All strains of K. pneumoniae were susceptible to carbapenems. Resistance rates to piperacillin and gentamicin were higher in ESBL-producing strains compared with non-ESBL-producing strains (94.7% (n=18) vs. 15.8% (n=3) (p<0.05) for gentamicin and 100% (n=19) vs. 36.8% (n=7) (p<0.001) for piperacillin, respectively). No significant differences were found in the resistance rates to amikacin and ciprofloxacin.
The resistance of K. pneumoniae strains, isolated from bronchial secretions of patients treated in ICUs at KUMH, to third-generation cephalosporins increased significantly during the period of 2001-2004. However, the proportion of ESBL-producing strains remained unchanged. Resistance to certain antibacterials could be suspected if ESBL production is present - higher rates of resistance to piperacillin and gentamicin were found in the group of ESBL-producing K. pneumoniae strains.
确定肺炎克雷伯菌中对第三代头孢菌素耐药的菌株产生超广谱β-内酰胺酶(ESBLs)与这些菌株对抗生素耐药性之间的关系。
从考纳斯医科大学医院(KUMH)重症监护病房(ICU)接受治疗的患者支气管分泌物中获取了157株对第三代头孢菌素耐药的肺炎克雷伯菌培养物。对分泌物进行培养,并根据美国国家临床实验室标准委员会(NCCLS)的建议,在KUMH微生物实验室进行抗菌药敏试验。采用双纸片协同试验方法,对可能产生ESBL的肺炎克雷伯菌菌株通过E试验进行进一步检测。比较了对第三代抗生素耐药的产ESBL和不产ESBL的肺炎克雷伯菌菌株对碳青霉烯类、哌拉西林、庆大霉素、阿米卡星和环丙沙星的耐药性。
2001年近三分之一的肺炎克雷伯菌菌株(n = 28,32.8%)对第三代头孢菌素耐药,2004年为50.0%(n = 36)(p < 0.05)。2001年一半的菌株(n = 7,50%)产ESBL,2004年为50%(n = 12)。所有肺炎克雷伯菌菌株对碳青霉烯类均敏感。与不产ESBL的菌株相比,产ESBL的菌株对哌拉西林和庆大霉素的耐药率更高(庆大霉素分别为94.7%(n = 18)对15.8%(n = 3)(p < 0.05),哌拉西林为100%(n = 19)对36.8%(n = 7)(p < 0.001))。对阿米卡星和环丙沙星的耐药率未发现显著差异。
在2001 - 2004年期间,从KUMH的ICU接受治疗患者支气管分泌物中分离出的肺炎克雷伯菌菌株对第三代头孢菌素的耐药性显著增加,但产ESBL菌株的比例保持不变。如果存在ESBL产生,则可能怀疑对某些抗菌药物耐药——在产ESBL的肺炎克雷伯菌菌株组中发现对哌拉西林和庆大霉素的耐药率更高。